We conducted a phase 3, double-blind, placebo-controlled study involving untreated and previously treated patients with chronic HCV genotype 1, 2, 4, 5, or 6 infection, including those with ...

Patients with genotype 3 infection were randomly assigned in a 2:1 ratio to receive 12 weeks of treatment with either glecaprevir–pibrentasvir or sofosbuvir–daclatasvir.

Adding the direct-acting hepatitis C drug simeprevir to pegylated interferon and ribavirin produced high response rates for HIV-positive people co-infected with HCV genotype 1, researchers reported at ...

In one of the largest prevalence studies to date, researchers from the UK provide national, regional, and global genotype prevalence estimates for the hepatitis C virus. Findings published in ...

Hepatitis C virus genotype 1 is the most prevalent genotype and accounts for 83.4 million infections, or 46.2% of all cases, worldwide, according to a study published in Hepatology.

The HCV protease inhibitor faldaprevir added to pegylated interferon and ribavirin increased the likelihood that HIV/HCV co-infected people would achieve a sustained virological response at four weeks ...

The approval was based on data from three Phase 3 studies (ION-1, ION-2 and ION-3) evaluating 8, 12, or 24 weeks of treatment with Harvoni, with or without ribavirin, among nearly 2,000 genotype 1 ...

Data from the genotype 1 null responder arm of the study will be presented at an upcoming scientific conference. Results from ongoing studies in genotype 1 treatment-naïve patients will be ...

Hepatitis C virus genotype 1 is the most prevalent with 83.4 million infections accounting for 46.2% of all cases worldwide, according to new research data.

Peller is once again trending for the wrong reasons after his confusing reaction to questions about his genotype ...

Viekira Pak is indicated for chronic hepatitis C virus (HCV) genotype 1 infection, with or without ribavirin.

Final results of phase III trials show that the newly approved drug telaprevir in combination therapy was more effective than standard therapy alone for treatment of chronic HCV infection.